Assembly Biosciences Inc
NASDAQ:ASMB

Watchlist Manager
Assembly Biosciences Inc Logo
Assembly Biosciences Inc
NASDAQ:ASMB
Watchlist
Price: 17.25 USD 7.34% Market Closed
Market Cap: 131.8m USD

Wall Street
Price Targets

ASMB Price Targets Summary
Assembly Biosciences Inc

Wall Street analysts forecast ASMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASMB is 32.3 USD with a low forecast of 29.29 USD and a high forecast of 36.75 USD.

Lowest
Price Target
29.29 USD
70% Upside
Average
Price Target
32.3 USD
87% Upside
Highest
Price Target
36.75 USD
113% Upside
Assembly Biosciences Inc Competitors:
Price Targets
NVAX
Novavax Inc
136% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
30% Upside
PHARM
Pharming Group NV
501% Upside
ACLX
Arcellx Inc
71% Upside
1952
Everest Medicines Ltd
1% Downside
2487
Cutia Therapeutics
2% Downside
688428
InnoCare Pharma Ltd
6% Downside
300841
Chengdu Kanghua Biological Products Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Assembly Biosciences Inc

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Assembly Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASMB's stock price target?
Price Target
32.3 USD

According to Wall Street analysts, the average 1-year price target for ASMB is 32.3 USD with a low forecast of 29.29 USD and a high forecast of 36.75 USD.

What is Assembly Biosciences Inc's Revenue forecast?
Projected CAGR
29%

The compound annual growth rate of Assembly Biosciences Inc's revenue for the next 3 years is 29%.

Back to Top